Filing Details

Accession Number:
0000899243-19-005964
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-04 20:13:44
Reporting Period:
2019-02-28
Accepted Time:
2019-03-04 20:13:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1751299 Kaleido Biosciences Inc. KLDO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219016 W Michael Bonney C/o Kaleido Biosciences, Inc.
65 Hayden Avenue
Lexington MA 02421
Executive Chair Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-28 68,965 $13.95 1,005,968 No 4 P Direct
Common Stock Acquisiton 2019-02-28 2,555 $14.65 1,008,523 No 4 P Direct
Common Stock Acquisiton 2019-03-04 417,673 $0.00 1,426,196 No 4 C Direct
Common Stock Acquisiton 2019-03-04 225,000 $0.00 225,000 No 4 C Indirect See Foonote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 C Direct
No 4 C Indirect See Foonote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2019-03-04 835,347 $0.00 417,673 $0.00
Common Stock Series B Preferred Stock Disposition 2019-03-04 450,000 $0.00 225,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Indirect
Footnotes
  1. Each share of Series B Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 ("Common Stock"), on a one-for-two basis upon the closing of the Issuer's initial public offering.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.50 to $14.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.52 to $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  4. Shares held in the Michael and Alison Bonney 2016 Irrevocable Trust, which has an independent trustee.